Literature DB >> 20833661

Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear?

Laurent Beaugerie1, Alexander L Gerbes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20833661     DOI： 10.1136/gut.2010.217331

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

Review 1.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

2.  Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.

Authors:  Jing Fang; Wenge Li; Xiangxin Peng; Zhao Tan; Min Tan; Cong Zhang; Wenbo Wang; Zhihong Xu; Gumin Zhou
Journal:  Int Urol Nephrol       Date:  2016-12-28       Impact factor: 2.370

Review 3.  Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

Authors:  Pilar López-Serrano; Jose Lázaro Pérez-Calle; Maria Dolores Sánchez-Tembleque
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.